AMELIA JONES: Open Payments
NPI 1013562065 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$320 in 8 payments from 6 companies in 2025. Trend: 2023 $297 · 2024 $265 · 2025 $320
Food & beverage: $320
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $135 |
| Celgene Corporation | 2 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Incyte Corporation | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
Products named: BREYANZI, VONVENDI, JAKAFI, LYNOZYFIC, Cresemba.
Industry payments across CA — which companies pay providers there.
